Elephas
Business Services · Wisconsin, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1 Erdman Pl Ste 100, Madison, Wisconsin,...Phone Number
(773) 426-9399Website
www.elephas.comRevenue
$14.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Elephas
Elephas develops an oncology platform that predicts patient response to immunotherapy treatments. The company's technology utilizes live tissue from biopsies to measure immunotherapy response within 72 hours, preserving the native tumor microenvironment to capture the complex interplay of genes, proteins, tumor cells, stroma, and immune cells. The tumor-agnostic platform is designed to evaluate treatment across multiple cancer indications and immunotherapy types, enabling oncologists and pharmaceutical companies to predict clinical treatment outcomes before treatment begins and accelerate drug development.Explore more
Elephas Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Elephas your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Elephas has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Elephas launches new products
Congratulate Masked Content for being promoted to Masked Content at Elephas
Website visits: Recent activity has been detected on your website
Check out if Elephas is spiking on competitors!
Click to see if Elephas had a recent Job posting/layoffs
Earning: See what the market has to say on Elephas recently announced quarterly report
Elephas, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Elephas has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Elephas as Masked Content
Find more new buyers
Compare Similar Companies to Elephas
Compare insights from companies similar to Elephas, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Elephas is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Elephas is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Elephas.
Elephas financials insights
Gather financial insights about Elephas, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series B
$41.5M
2024
Series C
$55M
2025
Other Financing Round
$40M
Elephas Tech Stack
A closer look at the technologies used by Elephas
Most Recent Scoops
Person-Based
Business Intelligence, Analytics & Insights, Bioengineering, Artificial Intelligence
Open Position
Hiring Plans
Elephas has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Open Position
Person-Based
Elephas News & Media
Indian American Premal Patel joins Elephas Biosciences as CMO
Move strengthens Elephas’ scientific and clinical leadership ahead of commercial launch of its live tumor immunology platformELEPHAS BIOSCIENCES STRENGTHENS SCIENTIFIC AND CLINICAL LEADERSHIP AS COMPANY ADVANCES TOWARD COMMERCIAL AVAILABILITY OF ITS LIVE-TUMOR IMMUNOLOGY PLATFORM
Premal H. Patel, MD, PhD, appointed Chief Medical Officer; Dr. Michael F. Giordano joins Scientific Advisory Board MADISON, Wis., Jan. 8, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for...JOURNAL OF TRANSLATIONAL MEDICINE PUBLISHES PAPER HIGHLIGHTING POTENTIAL OF THE ELEPHAS LIVE™ PLATFORM TO TRANSFORM IMMUNOTHERAPY OUTCOMES
Innovative Platform Aims to Boost Response Rates and Improve Lives of Cancer Patients MADISON, Wis., Jan. 6, 2026 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a privately held leader in precision oncology, today announced the publication of a foundational paper in Journal of...ELEPHAS BIOSCIENCES APPOINTS DR. JOSH ROUTH TO LEAD ELEPHAS LABORATORIES
Recognized leader in pathology joins mission to begin clinically offering eLIVE™ to oncologists and pathologists MADISON, Wis., Dec. 2, 2025 /PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Elephas
Sign Up For FreeTo access detailed company insights
Elephas develops an oncology platform that predicts patient response to immunotherapy treatments. The company's technology utilizes live tissue from biopsies to measure immunotherapy response within 72 hours, preserving the native tumor microenvironment to capture the complex interplay of genes, proteins, tumor cells, stroma, and immune cells. The... Read More
